[go: up one dir, main page]

PE107899A1 - Derivados de pirrolopirrolona como inhibidores de elastasa leucocitaria - Google Patents

Derivados de pirrolopirrolona como inhibidores de elastasa leucocitaria

Info

Publication number
PE107899A1
PE107899A1 PE1998000828A PE00082898A PE107899A1 PE 107899 A1 PE107899 A1 PE 107899A1 PE 1998000828 A PE1998000828 A PE 1998000828A PE 00082898 A PE00082898 A PE 00082898A PE 107899 A1 PE107899 A1 PE 107899A1
Authority
PE
Peru
Prior art keywords
alkyl
compound
pirrolopyrolone
leucocitary
derivatives
Prior art date
Application number
PE1998000828A
Other languages
English (en)
Inventor
Michael Dennis Dowle
Lee Andrew Harrison
Graham George Adam Inglis
Geoffrey Duke Edward Clarke
Harry Finch
Pritom Shah
Martin Redpath Johnson
Simon John Fawcett Macdonald
Robin Andrew Smith
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9719189.4A external-priority patent/GB9719189D0/en
Priority claimed from GBGB9719183.7A external-priority patent/GB9719183D0/en
Priority claimed from GBGB9719290.0A external-priority patent/GB9719290D0/en
Priority claimed from GBGB9803611.4A external-priority patent/GB9803611D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of PE107899A1 publication Critical patent/PE107899A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

SE REFIERE A UN COMPUESTO DE FORMULA I, R1 ES ALQUILO C1-C6; R2 ES ALQUILO C2-C4 o ALQUENILO C2-C4; X ES CO o SO2; HET ES UN MONOCICLO O BICICLO AROMATICO DE 5-10 MIEMBROS OPCIONALMENTE SUSTITUIDO; n ES 0-4; R3 Y R4 SON H, ALQUILO C1-C8, -(CH2)(1-4)CONR5R6, CO(ALQUILO C1-C4), (CH2)(CERO-2)Fen; Fen ES FENILO OPCIONALMENTE SUSTITUIDO; O NR3R4 SON AZETIDINILO, PIRROLIDINILO, PIPERIDINILO,ENTRE OTROS; R5 Y R6 SON H o ALQUILO C1-C4. UN COMPUESTO PREFERIDO ES (3S,3aS,6aR)-3-ISOPROPIL-1-METANSULFONIL-4-(2-PIRROLIDIN-1-ILMETIL-OXAZOL-4-CARBONIL)-HEXAHIDRO-PIRROLO[3,2-b]PIRROL-2-ONA; ENTRE OTROS. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION. EL COMPUESTO I ES UN INHIBIDOR DE LA ELASTASA NEUTROFILA Y PUEDE SER UTIL PARA EL TRATAMIENTO DE BRONQUITIS CRONICA O ENFERMEDAD PULMONAR OBSTRUCTIVA CRONICA, ASMA
PE1998000828A 1997-09-09 1998-09-04 Derivados de pirrolopirrolona como inhibidores de elastasa leucocitaria PE107899A1 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9719189.4A GB9719189D0 (en) 1997-09-09 1997-09-09 New therapeutic method
GBGB9719183.7A GB9719183D0 (en) 1997-09-09 1997-09-09 Compounds
GBGB9719290.0A GB9719290D0 (en) 1997-09-10 1997-09-10 Compounds
GBGB9803611.4A GB9803611D0 (en) 1998-02-21 1998-02-21 Compounds

Publications (1)

Publication Number Publication Date
PE107899A1 true PE107899A1 (es) 1999-11-17

Family

ID=27451698

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1998000828A PE107899A1 (es) 1997-09-09 1998-09-04 Derivados de pirrolopirrolona como inhibidores de elastasa leucocitaria

Country Status (24)

Country Link
EP (1) EP1003748A2 (es)
JP (1) JP2001515904A (es)
KR (1) KR20010023766A (es)
CN (1) CN1278820A (es)
AP (1) AP2000001761A0 (es)
AR (1) AR017072A1 (es)
AU (1) AU9741298A (es)
BR (1) BR9812062A (es)
CA (1) CA2303176A1 (es)
CO (1) CO4970719A1 (es)
EA (1) EA200000204A1 (es)
EE (1) EE200000138A (es)
HU (1) HUP0004644A3 (es)
ID (1) ID24452A (es)
IL (1) IL134791A0 (es)
IS (1) IS5391A (es)
MA (1) MA26543A1 (es)
NO (1) NO20001198L (es)
NZ (1) NZ503130A (es)
PE (1) PE107899A1 (es)
PL (1) PL339176A1 (es)
SK (1) SK3192000A3 (es)
TR (1) TR200000907T2 (es)
WO (1) WO1999012933A2 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9905418D0 (en) * 1999-03-09 1999-05-05 Glaxo Group Ltd Process
EP1771432B1 (en) 2004-03-31 2010-12-08 Janssen Pharmaceutica NV Non-imidazole heterocyclic compounds as histamine h3 receptor modulators
DE102004024772A1 (de) 2004-05-17 2005-12-22 Grünenthal GmbH Substituierte 5-Aminomethyl-1H-pyrrol-2-carbonsäureamide
TWI355380B (en) 2004-05-27 2012-01-01 Nihon Nohyaku Co Ltd Substituted pyrazinecarboxanilide derivatives or s
JP4853759B2 (ja) * 2004-05-27 2012-01-11 日本農薬株式会社 置換ピラジンカルボン酸アニリド誘導体又はその塩類、その中間体及び農園芸用薬剤並びにその使用方法
GB2418427A (en) 2004-09-02 2006-03-29 Univ Cambridge Tech Ligands for G-protein coupled receptors
MX2007005137A (es) 2004-11-23 2007-06-22 Warner Lambert Co Derivados del acido 7-(2h-pyrazol-3-il)-3, 5-dihidroxi-heptanoico como inhibidores de hmg co-a reductasa para el tratamiento de lipidemia.
US8198288B2 (en) 2006-05-04 2012-06-12 Pulmagen Therapeutics (Inflammation) Limited Tetrahydropyrrolopyrimidinediones and their use in therapy
ATE480543T1 (de) 2006-05-04 2010-09-15 Pulmagen Therapeutics Inflamma Tetrahydropyrrolopyrimidindione und ihre verwendung als inhibitoren der humanen neutrophilen elastase
US7662967B2 (en) 2007-08-02 2010-02-16 Cambridge Enterprise Limited Anti-inflammatory compounds and compositions
GB2452696B (en) 2007-08-02 2009-09-23 Cambridge Entpr Ltd 3-(2',2'-dimethylpropanoylamino)-tetrahydropyridin-2-one and its use in pharmaceutical compositions
WO2009060206A1 (en) * 2007-11-07 2009-05-14 Argenta Discovery Limited 3,4,6,7-tetrahydro-1h-pyrrolo[3,4-d]pyrimidine-2,5-diones and their therapeutic use
US20110212181A1 (en) * 2010-02-26 2011-09-01 The University Of Hong Kong Compositions and methods for treating chronic respiratory inflammation
US20220354833A1 (en) 2019-09-17 2022-11-10 Mereo Biopharma 4 Limited Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host disease
LT4106757T (lt) 2020-04-16 2023-11-10 Mereo Biopharma 4 Limited Neutrofilų elastazės inhibitoriaus alvelestato panaudojimas kvėpavimo sistemos ligų, nulemtų alfa-1 antitripsino nepakankamumo, gydymui
AU2022373971A1 (en) 2021-10-20 2024-04-04 Mereo Biopharma 4 Limited Neutrophil elastase inhibitors for use in the treatment of fibrosis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9211783D0 (en) * 1992-06-04 1992-07-15 Ici Plc Amide derivatives
GB9402680D0 (en) * 1994-02-11 1994-04-06 Zeneca Ltd Pyrrolidine derivatives
ATE261969T1 (de) * 1996-03-28 2004-04-15 Glaxo Group Ltd Pyrrolopyrrolone als inhibitoren von neutrophiler elastase

Also Published As

Publication number Publication date
MA26543A1 (fr) 2004-12-20
NO20001198L (no) 2000-05-08
ID24452A (id) 2000-07-20
AP2000001761A0 (en) 2000-03-31
CA2303176A1 (en) 1999-03-18
NZ503130A (en) 2001-08-31
EP1003748A2 (en) 2000-05-31
JP2001515904A (ja) 2001-09-25
AR017072A1 (es) 2001-08-22
IS5391A (is) 2000-02-29
WO1999012933A2 (en) 1999-03-18
NO20001198D0 (no) 2000-03-08
EE200000138A (et) 2001-02-15
BR9812062A (pt) 2000-09-26
CO4970719A1 (es) 2000-11-07
SK3192000A3 (en) 2001-03-12
WO1999012933A3 (en) 1999-05-27
PL339176A1 (en) 2000-12-04
KR20010023766A (ko) 2001-03-26
HUP0004644A3 (en) 2002-01-28
IL134791A0 (en) 2001-04-30
CN1278820A (zh) 2001-01-03
TR200000907T2 (tr) 2000-11-21
AU9741298A (en) 1999-03-29
EA200000204A1 (ru) 2000-10-30
HUP0004644A2 (hu) 2001-09-28

Similar Documents

Publication Publication Date Title
PE107899A1 (es) Derivados de pirrolopirrolona como inhibidores de elastasa leucocitaria
EA200100755A1 (ru) 4-оксо-1,4-дигидро-3-хинолинкарбоксамиды как антивирусные агенты
ATE292628T1 (de) Chinazolinderivate
DK0388948T3 (da) Acryloylsubstituerede pyrrolderivater
DE60307179D1 (de) Vor UV-Strahlen schützende Zusammensetzungen
AU6645998A (en) Oxygen or sulfur containing heteroaromatics as factor xa inhibitors
PH23979A (en) 2,3-dihydroxy-quinolines and pharmaceutical composition containing them
DK1401837T3 (da) Purinderivater som A2B-adenosinreceptorantagonister
NO992259D0 (no) Ny anvendelse for 1,3-propandiolderivater
EA200101203A1 (ru) Производные пурина
DK0790987T3 (da) Aminotetrazol-derivater, der er anvendelige som nitrogenoxidsynthaseinhibitorer
AU3015289A (en) 2'-deoxy-5-fluorouridine derivatives
DE69728544D1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
EA200100516A1 (ru) Производные 3,3-биарилпиперидина и 2,2-биарилморфолина
DE60014394D1 (de) Aminobenzophenone als inhibitoren von il-1beta und tnf-alpha
MX9400901A (es) Microbicidas
WO2002014456A3 (en) Use of trioxepans in ignition improved fuels

Legal Events

Date Code Title Description
FD Application declared void or lapsed